Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release Syndrome in Hospitalized Patients with COVID-19
Stock Information for Aclaris Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.